Skip to main content

Table 3 Distribution of CysC proteoforms concentrations by DM and CKD groups

From: The association of plasma cystatin C proteoforms with diabetic chronic kidney disease

 

N1/N2/N3

Control

DM

CKD

p-value

Native CysC (mg/L)

33/34/44

1.09 (0.71,1.35)

1.15(0.97,1.48)

1.59 (1.07, 2.02)

<0.01a

CysC des-S (mg/L)

33/34/44

0.03 (0.025,0.046)

0.039 (0.03,0.05)

0.059 (0.035,0.08)

<0.01b

CysC des-SSP (mg/L)

33/34/44

0.06 (0.04,0.09)

0.053 (0.02, 0.071)

0.094(0.035, 0.14)

<0.01c

  1. Median (25th percentile, 75th percentile). Statistical significance defined with a p < 0.02. Groups compared with ANOVA followed by Tukey’s pairwise comparisons
  2. N1 = Control
  3. N2 = DM
  4. N3 = CKD
  5. aNative CysC
  6. In DM vs. controls, p = 0.6
  7. In CKD vs. DM, p = 0.02
  8. In CKD vs. controls, p = 0.001
  9. bCysC des-S
  10. In DM vs. controls, p = 0.8
  11. In CKD vs. DM, p = 0.002
  12. In CKD vs. controls, p = 0.0002
  13. cCysC des-SSP
  14. In DM vs. controls, p = 0.9
  15. In CKD vs. DM, p = 0.008
  16. In CKD vs. controls, p = 0.002
Back to article page

Proteome Science

ISSN: 1477-5956